Financials
Financial year 2024
PHARMACIE LEPIECE from Chaudfontaine, company number BE0870964087, closed financial year 2024 with a result of € 26,378 after tax. For that financial year PHARMACIE LEPIECE recorded a gross margin of € 172,446 and equity of € 102,301. Compared with financial year 2023, the result moved from € 77,265 to € 26,378. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 25, 2025.
€ 102,301
▼ 31% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 26,378
▼ 66% vs 2023
Profit after tax over the fiscal year.
€ 45,431
▼ 38% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 72,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
€ 131,920
▲ 6% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,129
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 69,334
▲ 30% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 23,164
▼ 18% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 222,391 | € 245,882 | € 232,264 | € 172,446 | ▼ 26% |
| Profit after taxes | € 83,797 | € 91,791 | € 77,265 | € 26,378 | ▼ 66% |
| Equity | € 162,868 | € 214,659 | € 147,924 | € 102,301 | ▼ 31% |
| Total debts | € 130,302 | € 72,231 | € 232,328 | € 173,529 | ▼ 25% |
| Cash | € 124,461 | € 72,987 | € 73,108 | € 45,431 | ▼ 38% |
| Land & buildings | - | - | € 1,176 | € 2,960 | ▲ 152% |
| Retained profit | € 150,468 | € 202,259 | € 135,524 | € 89,901 | ▼ 34% |
| Dividend | € 0 | € 40,000 | € 144,000 | € 72,000 | ▼ 50% |
| Bank debt | € 4,667 | € 667 | € 0 | € 0 | |
| Balance sheet total | € 293,170 | € 286,890 | € 380,251 | € 275,831 | ▼ 27% |
Key figures of PHARMACIE LEPIECE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMACIE LEPIECE?
What happened at PHARMACIE LEPIECE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 26,378 (▼ 66% vs 2023). Source: NBB ↗
- MABIMA became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Chaudfontaine. KBO
In short
From € 83,797 profit in 2021 to € 26,378 profit in 2024.
Paid € 87,482 in corporate taxes since 2021.
Best year ever: 2022, with € 91,791 profit.
Paid out € 256,000 in dividends to the owners in total.
A new publication or filing at PHARMACIE LEPIECE? We notify you, reason included.
Follow PHARMACIE LEPIECEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MABIMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE LEPIECEBehind PHARMACIE LEPIECE is MABIMA. The shares are held by MABIMA (100%).
Establishments
Establishment units
Physical locations of this company
Avenue François Bovesse 6/A
4053 Chaudfontaine
Avenue François Bovesse 6
4053 Chaudfontaine
Active since 23 December 2004
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
HETZNER-AS, DE
Website info
Features
Security
Network
Details
- Company number
- 0870.964.087
- VAT number
- BE 0870.964.087
- Registered office
- Avenue François Bovesse 6/A, 4053 Chaudfontaine
- Names & denominations
- PHARMACIE LEPIECE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2005
- Peppol
- Active · Active since 10 Oct 2025
- Contact
- pharmacielepiece.be [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers